KR20010017053A - Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper - Google Patents

Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper Download PDF

Info

Publication number
KR20010017053A
KR20010017053A KR1019990032359A KR19990032359A KR20010017053A KR 20010017053 A KR20010017053 A KR 20010017053A KR 1019990032359 A KR1019990032359 A KR 1019990032359A KR 19990032359 A KR19990032359 A KR 19990032359A KR 20010017053 A KR20010017053 A KR 20010017053A
Authority
KR
South Korea
Prior art keywords
extract
lasiophaera
calvatin
seu
hydropiper
Prior art date
Application number
KR1019990032359A
Other languages
Korean (ko)
Other versions
KR100585468B1 (en
Inventor
진무현
김호정
김청택
김진준
Original Assignee
성재갑
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사 엘지화학 filed Critical 성재갑
Priority to KR1019990032359A priority Critical patent/KR100585468B1/en
Publication of KR20010017053A publication Critical patent/KR20010017053A/en
Application granted granted Critical
Publication of KR100585468B1 publication Critical patent/KR100585468B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9741Pteridophyta [ferns]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: A cosmetic composition containing Calyx kaki extract, Lasiophaera Seu Calvatin extract, or Fructus polygoni Hydropiper extract as an effective ingredient is provided, which improves liver spots and freckles, and shows good skin whitening effect without side effect. CONSTITUTION: A process for the preparation of Calyx kaki extract, Lasiophaera Seu Calvatin extract, or Fructus polygoni Hydropiper extract comprises: pulverizing each Calyx kaki, Lasiophaera Seu Calvatin, or Fructus polygoni Hydropiper, and extracting by boiling 3hrs in a circulation extractor after adding water, anhydrous or hydrated primary alcohol of carbon number 1-4, ethylacetate or acetone; filtering with a 100mesh filter sheet, and extracting the residue one more time by same process; adding each extract, and filtering with a Whatman No.2 filter sheet at room temperature to eliminate non-soluble materials; concentrating under decompression at 60deg.C using a distiller with a cooling condenser, and freeze-drying to get each extract powder. The cosmetic composition contains 0.0001-10.0wt.% of Calyx kaki extract, Lasiophaera Seu Calvatin extract, or Fructus polygoni Hydropiper extract.

Description

시체 추출물, 마발 추출물 또는 랄료 추출물을 함유하는 화장료조성물{Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper}Cosmetic composition containing corpse extract, quince extract or raal extract extract {Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper}

본 발명은 시체 추출물, 마발 추출물 또는 랄료 추출물을 함유하는 화장료 조성물에 관한 것이다. 보다 상세하게는 본 발명은 멜라닌 생성 억제 효과가 우수한 시체 추출물, 마발 추출물 및 랄료 추출물중에서 선택된 1종 이상을 유효성분으로 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a carcass extract, a hair extract or a raal extract. More specifically, the present invention relates to a cosmetic composition containing at least one selected from carcass extracts, horsetail extracts and raal extracts with excellent melanin production inhibitory effect as an active ingredient.

희고 고운 피부를 갖고자 하는 것은 모든 사람의 한결같은 소망이다. 사람의 피부색은 피부내 멜라닌(melanin)의 농도와 분포에 따라 유전적으로 결정되나, 태양 자외선이나 피로, 스트레스 등의 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어 진다. 그러나 멜라닌이 만들어지는 경로는 알려져 있으나, 티로시나제가 작용하는 이전 단계인 멜라닌합성을 유도하는 메카니즘(mechanism)이 무엇인지에 대해서는 아직도 자세히 밝혀지지 않고 있다.It is everyone's constant desire to have white, fair skin. Human skin color is genetically determined by the concentration and distribution of melanin in the skin, but is also influenced by environmental or physiological conditions such as solar ultraviolet rays, fatigue and stress. Melanin is a type of amino acid tyrosine (tyrosine) enzymes called tyrosinase (tyrosinase) acts to convert to dopa (DOPA), dopaquinone (dopaquinone) is produced through a non-enzymatic oxidation reaction. However, although the pathway through which melanin is made is known, it is still unknown in detail the mechanism by which tyrosinase acts, the mechanism that induces melanin synthesis.

한편 멜라닌 색소의 합성을 저해함으로서 피부 톤을 밝게하여 피부 미백을 실현할 수 있을 뿐만 아니라 자외선, 호르몬, 유전에 기인한 기미, 주근깨 등의 피부 과색소 침착증의 개선이 가능하다.On the other hand, by inhibiting the synthesis of melanin pigment can not only realize the skin whitening by brightening the skin tone, but also improve the hyperpigmentation of skin such as blemishes, freckles due to ultraviolet rays, hormones, heredity.

이에 종래에는 하이드로퀴논(hydroquinone)이나 아스콜빈산(ascorbic acid), 고지산(kojic acid), 글루타치온(glutathione)같은 티로시나제에 저해 활성을 갖는 물질을 연고나 화장료에 배합하여, 피부 미백이나 기미, 주근깨 개선의 목적에 사용하여 왔으나, 하이드로퀴논의 미백효과는 인정되지만 피부자극성이 심하여 사용량이 극히 제한된다. 또한 아스콜빈산은 산화되기 쉬워 이를 배합한 화장료는 변색, 변취되는 등의 문제를 야기하며 글루타치온, 시스테인 등의 티올계 화합물은 특유의 불쾌한 냄새가 나며 경피흡수에 문제가 있다. 또한 이들의 배당체 및 유도체들은 극성이 높아 화장료의 배합 성분으로 사용하기에는 문제가 있다. 또한 태반 추출물 등은 미백 효과가 불충분하다는 문제가 있다.Therefore, conventionally, substances having inhibitory activity against tyrosinase, such as hydroquinone, ascorbic acid, kojic acid, and glutathione, are incorporated into ointments or cosmetics, and thus whitening, blemishes, and freckles of skin. Although it has been used for the purpose of improvement, the whitening effect of hydroquinone is recognized, but the amount of use is extremely limited due to severe skin irritation. In addition, ascorbic acid is easily oxidized, and cosmetics containing the same cause problems such as discoloration and deodorization, and thiol compounds such as glutathione and cysteine have a characteristic unpleasant odor and have problems with transdermal absorption. In addition, these glycosides and derivatives have a high polarity, so there is a problem to use them as a component of a cosmetic. In addition, placenta extract has a problem that the whitening effect is insufficient.

이에 본 발명자들은 멜라닌 합성 유도 자체를 억제하는 물질까지 스크리닝(screening)할 수 있는 쥐의 멜라노마 세포(B16 mouse melanoma cell)를 이용하여 천연에서 자생하는 동식물들을 대상으로 새로운 미백제를 개발하고자 수많은 연구와 실험을 거듭한 결과, 시체 추출물, 마발 추출물, 랄료 추출물에 매우 강력한 멜라닌 생성 억제 효과와 미백효과가 있음을 밝혀내고 본 발명을 완성하게 되었다.Therefore, the present inventors have developed numerous whitening agents to develop new whitening agents in native plants and animals using B16 mouse melanoma cells, which can screen even substances that inhibit melanin synthesis induction. As a result of repeated experiments, it was found that the carcass extract, the hair extract extract, and the ralli extract have a very strong melanin production inhibitory effect and a whitening effect, and completed the present invention.

본 발명은 시체추출물, 마발추출물 및 랄료 추출물중에서 선택된 1종 이상을 유효성분으로 함유하는 것을 특징으로 하는 기미, 주근깨 개선 및 피부미백 효과를 나타내는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition exhibiting blemishes, freckles, and skin whitening effects, characterized in that it contains at least one selected from carcass extracts, quince extracts and raal extracts as an active ingredient.

시체(천근피)는 Ebenaceae과(감나무과)의 낙엽 교목인 Disopyros kaki L(감나무)의 열매꽃받침(감꼭지)으로써 라틴명은 Calyx kaki이다. 시체는 구토, 기침을 멎게하는 등의 한방약재로 사용되어 왔다(중약대사전). 시체의 구성성분으로는 숙신산, 퀘르세틴(quercetin), 캠프페롤(kaempferol), 네오디오스피린 (neodiospyrin), 베툴린 (Betulin), 다우코스테롤(Daucosterol)등의 물질을 포함하는 것으로 알려져 있다.The carcass is a calyx of the genus Disopyros kaki L, a deciduous tree of the Ebenaceae family. The Latin name is Calyx kaki. The body has been used as a herbal medicine such as vomiting and coughing. Carcass components are known to include substances such as succinic acid, quercetin, kaempferol, neodiospyrin, betulin, and daucosterol.

마발은 Lycopodiaceae(먼지버섯과)의 Lasioshpaera fenzlii Reich.(탈피마발)의 건조자실체로써 라틴명은 Lasiophaera Seu Calvatin이다. 마발은 외상 출혈 및 코피 등의 지혈, 항균 효능으로 한방에서 사용되어 왔다(중약대사전). 마발의 구성성분으로는 로이신(leucine), 티로신(tyrosine), 우레암(Uream), 에르고스테롤(Ergosterol), 겜마테인(Gemmatein )등의 물질을 포함하는 것으로 알려져 있다.Laval is the dried fruit of Lasioshpaera fenzlii Reich. Of the Lycopodiaceae family. The Latin name is Lasiophaera Seu Calvatin. The pill has been used in oriental medicine for hemostatic and antibacterial effects such as trauma bleeding and nosebleed (Chinese medicine dictionary). The constituents of the hair are known to include substances such as leucine, tyrosine, uream, ergosterol, and gemmatein.

랄료(요실)는 Polygonaceae(마디풀과)의 식물인 Polygonum hydropiper L.(여뀌)의 열매로써 라틴명은 Fructus polygoni Hydropiper 이다. 랄료는 이뇨, 토사복톡, 부종 등을 치료하는 한방약제로 사용되어 왔다(중약대사전). 랄료의 구성 성분으로는 갈릭산, 알라닌, 세린, 아르기닌, 퀘르세틴, 루틴(Rutin), 하이퍼옥시드(Hyperoside), 푸에긴(Fuegin), 드리멘올(Drimenol) 등의 물질을 포함하는 것으로 알려져 있다.Laurea is the fruit of Polygonum hydropiper L. (Glyphaceae), a plant of the Polygonaceae family. Latin name is Fructus polygoni Hydropiper. Lalary has been used as a herbal medicine to treat diuresis, tosaboktok, edema, etc. (Chinese medicine dictionary). The constituents of rallies are known to include substances such as gallic acid, alanine, serine, arginine, quercetin, rutin, hyperoxide, fuginin and drimeol. .

본 발명에 따르면, 약재로 구입할 수 있는 시체, 마발, 랄료를 탄소수 1-4개의 무수 또는 함수 저급알코올 또는 에틸아세테이트 또는 아세톤 등의 유기용매로 1차 추출한 후 감압 농축한 다음 동결건조하거나 분무건조하여 1차 추출물을 제조한다. 이러한 방법으로 제조된 시체, 마발, 랄료 추출물은 쥐의 멜라노마 세포(B-16 mouse melanoma cell)에서 매우 강력한 멜라닌 합성 저해 효과를 나타낸다. 또한 건조된 시체, 마발, 랄료 추출물로 피부외용 연고나 화장료를 제조하여 사람의 피부에 도포하였을 때, 피부 미백 효과가 매우 우수하다.According to the present invention, the carcass, marbal, and raal, which can be purchased as a medicine, are first extracted with an organic solvent such as anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms or ethyl acetate or acetone, and then concentrated under reduced pressure, and then lyophilized or spray dried. Prepare the primary extract. The carcass, marbal, and ralyo extracts prepared in this way have very potent melanin synthesis inhibitory effects in B-16 mouse melanoma cells. In addition, when the external body ointment or cosmetics are prepared with dried carcass, horsetail, and racial extract, and applied to human skin, the skin whitening effect is very excellent.

또한 생약제로 시판되는 시체, 마발, 랄료를 구입하여 잘게 분쇄하고 분쇄물 건조 중량에 대하여 5-20 부피의 물이나, 탄소수 1-4개의 무수 또는 함수 저급알코올, 에틸아세테이트 또는 아세톤으로 환류 냉각기가 달린 추출기에서 50-100℃로 1-5시간 가열하여 추출한다. 여과포로 여과한 후 잔사를 같은 방법으로 1회이상씩 더 추출한다. 추출액을 합하여 감압농축한 후 동결건조나 분무 건조하여 건조추출물을 얻는다. 건조된 시체, 마발, 랄료 추출물을 쥐의 멜라노마 세포(B-16 mouse melanoma cell)에 처리하였을 때, 매우 강력한 멜라닌 합성 저해효과를 나타낸다.In addition, commercially available carcasses, yams, and rallies are available for pulverization and are refluxed with 5-20 volumes of water or 1-4 anhydrous or lower alcohols, ethyl acetate or acetone with respect to the dry weight of the crushed powder. Extract by heating 1-5 hours at 50-100 ° C. in the extractor. After filtering with filter cloth, the residue is extracted one more time in the same manner. The extracts were combined and concentrated under reduced pressure, followed by freeze drying or spray drying to obtain a dry extract. When dried carcass, horsetail, and raloretus extracts were treated with B-16 mouse melanoma cells, they showed very potent melanin synthesis inhibitory effects.

상기와 같이 얻어진 시체, 마발, 랄료 추출물을 이용하여 피부외용 연고나 로션, 크림, 유연화장수, 영양화장수, 팩, 에센스 같은 여러 화장료를 제조한다. 시체, 마발, 랄료 추출물을 함유한 화장료를 제조하여 사람의 피부에 도포하였을 때 피부 미백 효과가 매우 우수한 것으로 나타났다. 또한 어떤 부작용도 발생하지 않아 시체, 마발, 랄료 추출물이 안전하고 효과가 매우 뛰어난 기미나 주근깨 개선 및 피부 미백제임을 알 수 있다.By using the obtained body, hair, raal extracts as described above to prepare a variety of cosmetics, such as skin external ointment or lotion, cream, supple cosmetics, nourishing cosmetics, packs, essences. It was found that the skin whitening effect was very excellent when the cosmetics containing the body, the hair, and the rala extract were prepared and applied to the skin of a person. In addition, no side effects occur, indicating that carcass, hydration and raal extracts are safe and highly effective for improving blemishes and freckles and skin whitening agents.

피부외용연고나 화장료를 제조함에 있어서, 시체추출물, 마발추출물, 랄료 추출물등은 건조 중량으로 0.0001-10.0중량%, 바람직하게는 0.0005-10.0중량%가 적당하다. 추출물의 농도가 0.0001 중량% 이하인 경우에는 뚜렷한 효과를 기대할 수 없으며, 10중량%이상의 농도에서는 함유량의 증가에 따라 더 이상의 효과 증가를 나타내지 않는다.In the preparation of external skin ointments or cosmetics, carcass extracts, horse extracts, raal extracts, etc. are appropriately 0.0001-10.0% by weight, preferably 0.0005-10.0% by weight in dry weight. If the concentration of the extract is less than 0.0001% by weight can not expect a distinct effect, at a concentration of more than 10% by weight does not show any increase in effect as the content increases.

이하, 실시예에 의거하여 본 발명을 자세히 설명하지만, 본 발명의 기술적 범위가 이들 실시예에만 한정되는 것이 아님을 밝혀둔다.Hereinafter, although this invention is demonstrated in detail based on an Example, it turns out that the technical scope of this invention is not limited only to these Examples.

실시예 1-18Example 1-18

시판되는 시체, 마발, 랄료를 구입하여 분쇄한 분쇄물 100g을 물이나, 탄소수 1-4개의 무수 또는 함수 저급알코올, 에틸아세테이트 또는 아세톤 등의 용매 3L에 넣고, 냉각콘덴서가 달린 환류 추출기에서 3시간 끓여 추출한 다음, 100 메쉬 여과포로 여과한 후 잔사를 같은 방법으로 1회 더 추출하였다. 각각의 추출액을 합하여 상온에서 화트만(Whatman) 2번 여과지로 여과하여 불용성물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후 동결건조하여 하기 표 1과 같이 각각의 건조 중량을 얻었다.100 g of a pulverized crushed product obtained from a commercially available carcass, a mash and a ralcum was put in 3 L of a solvent such as water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, ethyl acetate or acetone and 3 hours in a reflux extractor with a cooling capacitor. After boiling and extracting, the resultant was filtered with 100 mesh filter cloth and the residue was extracted once more in the same manner. Each extract was combined and filtered at room temperature with Whatman No. 2 filter paper to remove insoluble materials, and then concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser and freeze-dried to dry each dry weight as shown in Table 1 below. Got.

실험예 1Experimental Example 1

상기 실시예 1-18에 따라 얻어진 각 추출물들을 쥐의 멜로나마 세포(B-16 mouse melanoma cell)의 배양액에 첨가하여 세포수준에서의 미백 효과를 실험하였다(참조: Lotan R., Lotan D. Cancer Res. 40:3345-3350, 1980). 실시예 1-18에 따라 얻어진 각 추출물들을 최종농도가 0.005%가 되도록하여 하이드로퀴논 수용액과 함께 각각 B-16 멜라노마 세포의 배양배지에 첨가하여 3일간 배양한 후 세포들을 트립신(trypsin)처리하여 배양용기로부터 떼어내 원심분리한 후 멜라닌을 추출하였다. 이것에 수산화 나트륨 용액 (1N 농도) 1㎖를 가하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용, 400 나노미터(㎚)에서 흡광도를 측정하여 생성된 멜라닌의 양을 단위 세포수당 (106cell)의 흡광도로 나타내는 방법으로 수행하였으며, 대조군에 대한 상대적인 멜라닌 생성량을 저해율(%)로 계산하였다. 그 결과는 표 2에 나타내었다.Each of the extracts obtained according to Examples 1-18 was added to the culture medium of B-16 mouse melanoma cells to test the whitening effect at the cellular level (see Lotan R., Lotan D. Cancer). Res. 40: 3345-3350, 1980). Each extract obtained according to Example 1-18 was added to a culture medium of B-16 melanoma cells with a hydroquinone aqueous solution so as to have a final concentration of 0.005%, followed by incubation for 3 days, followed by trypsin treatment. Melanin was extracted from the culture vessel by centrifugation. Sodium hydroxide solution thereto (1N concentration) was added to dissolve the melanin 1㎖ boiled 10 minutes using a spectrophotometer at 400 nanometers (㎚) the amount of the unit cell allowance (10 6 cell) of melanogenesis by measuring the absorbance at It was carried out by the method shown in the absorbance, the relative melanin production relative to the control was calculated as the inhibition rate (%). The results are shown in Table 2.

상기 표2의 결과에서 볼 수 있듯이, 실시예 1-18에 따라 얻어진 각 시료들은 전혀 정제되지 않은 추출물임을 감안하면 기존에 알려진 미백물질인 하이드로퀴논과 비교할 때 배양된 쥐의 멜라노마 세포에 대하여 매우 강력한 멜라닌 생성 억제능이 있음을 알 수 있다.As can be seen from the results of Table 2, considering that each sample obtained according to Examples 1-18 is an extract that is not purified at all, compared to hydroquinone, a known whitening substance, it is very effective for the melanoma cells of cultured mice. It can be seen that there is a strong melanin production inhibitory ability.

실험예 2.Experimental Example 2.

실험예 1과 같은 방법으로 배양된 쥐의 멜라노마 세포에 대하여 실시예 1, 7 및 13의 추출물에 대하여 농도에 따른 멜라닌 생성 억제능을 조사하였다. 그 결과는 하기 표 3에 나타내었다.Melanoma cells of rats cultured in the same manner as in Experimental Example 1 were examined for their ability to inhibit melanin production according to the concentration of the extracts of Examples 1, 7 and 13. The results are shown in Table 3 below.

상기 표 3의 결과에서 볼 수 있듯이, 시체 추출물, 마발 추출물, 랄료 추출물은 배양된 쥐의 멜라노마 세포에 대하여 매우 강력한 멜라닌 생성 억제능을 가지고 있음을 알 수 있다. 하이드로퀴논은 저농도에서 강력한 멜라닌 생성 억제능을 가지지만 세포 독성이 심해 0.0001%이상에서는 실험을 할수 없는 것임에 반하여, 본 발명에서의 추출물들은 0.05%농도 이상에서도 세포독성을 나타내지 않으면서 사용가능한 최대량의 하이드로퀴논보다 높은 멜라닌 생성억제 효과를 갖는다. 또한 시체 추출물, 마발 추출물, 랄료 추출물이 단일물질이 아니고 혼합물질이라는 것을 고려할 때 매우 높은 멜라닌 생성 억제능을 가지고 있으므로, 기미나 주근깨 개선 또는 피부미백에 매우 유용하게 사용될 수 있다.As can be seen in the results of Table 3, it can be seen that the corpse extract, the valse extract, and the ralyo extract have a very strong melanin production inhibitory ability against the cultured melanoma cells. Hydroquinone has a strong melanin production inhibitory ability at low concentrations, but the cytotoxicity is severe and can not be tested at 0.0001% or more, whereas the extract of the present invention is the maximum amount of hydro that can be used without showing cytotoxicity even at a concentration of 0.05% or more It has a higher melanin production inhibitory effect than quinone. In addition, since the body extract, hair extract, and raal extract have a very high melanin production inhibitory ability, considering that it is not a single substance but a mixture, it can be very useful for improving freckles and freckles or skin whitening.

이하 시체, 마발, 랄료추출물을 함유하는 화장료의 처방예를 제조예에 의해 나타내었다.Hereinafter, the preparation example of the cosmetics containing a corpse, a paw, and a racial extract is shown by the manufacture example.

제조예 1-3 및 비교예 1. 피부외용연고Preparation Example 1-3 and Comparative Example 1. Skin Ointment

하기 표4에 나타낸 처방예에 따라 시체, 마발, 랄료 추출물을 함유하는 피부 외용연고를 제조하였다. 여기서 시체, 마발, 랄료 추출물은 각각 실시예 5, 11, 17의 것을 말한다.According to the prescription shown in Table 4 below, a skin external ointment containing a body, a paw, and a ladle extract was prepared. Here, carcass, horsetail, and ralyo extract refers to those of Examples 5, 11, and 17, respectively.

제조예 4-6 및 비교예 2. 크림화장료Preparation Example 4-6 and Comparative Example 2. Cream cosmetics

하기 표5에 나타낸 처방예에 따라 시체, 마발, 랄료 추출물을 함유하는 화장료 중 크림을 제오하였다. 여기서 시체, 마발, 랄료 추출물은 각각 실시예 5, 13, 21의 것을 말한다.According to the formulation shown in Table 5 below, the cream in the cosmetics containing the carcass, the paw, the rale extract extract. Herein, carcass, horseradish and ralyo extracts refer to those of Examples 5, 13 and 21, respectively.

제조예 7-9 및 비교예 3. 유연화장수Preparation Example 7-9 and Comparative Example 3. Flexible Cosmetics

하기 표6에 나타낸 처방예에 따라 시체, 마발, 랄료 추출물을 함유하는 화장료 중 유연화장수를 제조하였다. 여기서 시체, 마발, 랄료 추출물은 각각 실시예 5, 13, 21의 것을 말한다.According to the formulation shown in Table 6 below, a flexible cosmetic water in the cosmetics containing the carcass, scabbard, raalic extract was prepared. Herein, carcass, horseradish and ralyo extracts refer to those of Examples 5, 13 and 21, respectively.

제조예 10-12 및 비교예 4. 영양화장수Preparation Example 10-12 and Comparative Example 4. Nutrients

하기 표7에 나타낸 처방예에 따라 시체, 마발, 랄료 추출물을 함유하는 화장료 중 영양화장수를 제조하였다. 여기서 시체, 마발, 랄료 추출물은 각각 실시예 5, 13, 21의 것을 말한다.According to the prescription shown in Table 7 was prepared nutrient cosmetics in the cosmetics containing the carcass, horseshoe, raal extract. Herein, carcass, horseradish and ralyo extracts refer to those of Examples 5, 13 and 21, respectively.

제조예 13-15 및 비교예 5. 팩Preparation Example 13-15 and Comparative Example 5. Pack

하기 표8에 나타낸 처방예에 따라 시체, 마발, 랄료 추출물을 함유하는 화장료 중 팩을 제조하였다. 여기서 시체, 마발, 랄료 추출물은 각각 실시예 5, 13, 21의 것을 말한다.According to the formulation shown in Table 8 below, a pack of cosmetics containing carcass, horsetail, and raal extract was prepared. Herein, carcass, horseradish and ralyo extracts refer to those of Examples 5, 13 and 21, respectively.

제조예 16-18 및 비교예 6. 에센스Preparation Example 16-18 and Comparative Example 6. Essence

하기 표9에 나타낸 처방예에 따라 시체, 마발, 랄료 추출물을 함유하는 화장료 중 에센스를 제오하였다. 여기서 시체, 마발, 랄료 추출물은 각각 실시예 5, 13, 21의 것을 말한다.According to the prescription shown in Table 9 below, the essence of the cosmetics containing the carcass, the hair, the raal extract extracts. Herein, carcass, horseradish and ralyo extracts refer to those of Examples 5, 13 and 21, respectively.

실험예 3Experimental Example 3

건강한 남녀 20명씩을 선정하여 양팔의 하박부에 직경 7㎜ 크기의 구멍이 6개씩 2줄로 파인 알루미늄 호일을 붙이고, 팔에서 10㎝ 떨어진 거리에서 ORIEL solar simulator 1000W를 사용하여 60mJ/㎠의 광량을 조사하였다. 조사전에 70% 에탄올 수용액으로 조사부위를 잘 세척하였다. 조사하기 3일전부터 조사 후 3주째까지 1일 2회씩 제조예 1-18 및 비교예 1-6에 따라 제조된 시체, 마발, 랄료 추출물을 함유한 시료와 각각의 추출물이 함유되지 않은 기제를 한 쌍으로 같은 줄에 도포하였다(제조예 13, 14, 15 및 비교예 5의 팩 처방의 경우 도포한 다음 15분 후에 떼어내었다). 각각에 대하여 제조예와 비교예의 색소침착도를 육안으로 판정하고, 제조예가 비교예에 비해 색소침착을 억제한 정도를 뚜렷한 효과, 효과있음, 차이없음의 3단계로 평가하였으며, 그 결과는 표 10과 같다.Twenty healthy men and women were selected to attach aluminum foil in two rows of six holes with a diameter of 7 mm in the lower part of both arms and irradiated with 60mJ / ㎠ light using a ORIEL solar simulator 1000W at a distance of 10 cm from the arm. It was. The irradiation site was washed well with 70% ethanol aqueous solution before irradiation. Twice a day from 3 days before the irradiation to 3 weeks after the irradiation, the samples prepared according to Preparation Examples 1-18 and Comparative Examples 1-6 and the samples containing the extracts of carcasses, paws, and ladles were prepared. It was applied in the same row in pairs (for pack formulations of Preparation Examples 13, 14, 15 and Comparative Example 5, it was removed 15 minutes after application). For each, the pigmentation degree of the preparation example and the comparative example was visually judged, and the degree to which the preparation example suppressed the pigmentation compared to the comparative example was evaluated in three stages of distinct effects, effects, and no differences, and the results are shown in Table 10 Same as

위의 표 10의 결과에서 볼 수 있듯이, 제조예 1-18에 따라 제조된 시체, 마발, 랄료 추출물 함유 미백연고 및 화장료는 피시험자 20명 중에서 최소 9명 이상에 대하여 미백효과를 나타내었으며, 특히 많은 양의 지정, 와송 추출물 이 적용된 제조예 1, 2, 3과 비교예 1의 비교실험에서는 73%가 색소 침착 저해 효과를 보이고, 피부내에서 어떤 부작용도 나타나지 않아, 시체, 마발, 랄료 추출물이 안전하고 효과가 매우 뛰어난 기미나 주근깨 개선 또는 피부 미백용 화장료 임을 알 수 있다.As can be seen from the results in Table 10 above, the whitening ointment and cosmetics containing the carcass, bristles and raal extracts prepared according to Preparation Examples 1-18 showed a whitening effect on at least 9 of 20 subjects. In the comparative experiments of Preparation Examples 1, 2, 3 and Comparative Example 1, in which a large amount of designated, Wasong extract was applied, 73% showed pigmentation inhibitory effect, and no side effects occurred in the skin. It is a safe and effective cosmetics for improving blemishes and freckles or skin whitening.

본 발명에 따라 시체추출물, 마발추출물 및 랄료 추출물 중에서 선택된 1종 이상을 유효성분으로 함유하는 화장료조성물은 기미, 주근깨 개선 및 피부미백 효과가 우수하면서도 피부내에서 어떤 부작용도 나타나지 않는다.According to the present invention, the cosmetic composition containing at least one selected from carcass extracts, horse extracts and raal extracts as an active ingredient has excellent blemishes, freckles, and skin whitening effects, but does not exhibit any side effects in the skin.

Claims (3)

시체추출물, 마발추출물 및 랄료추출물중에서 선택된 1종 이을 유효성분으로 함유하는 것을 특징으로 하는 기미, 주근깨 개선 및 피부미백 효과를 나타내는 화장료 조성물.Cosmetic composition showing a blemish, freckles improvement and skin whitening effect, characterized in that it contains one or more selected from a body extract, a claw extract and a rale extract as an active ingredient. 제 1항에 있어서, 시체, 마발, 랄료 추출물을 건조 중량으로 0.0001-10.0중량% 함유하는 것을 특징으로하는 화장료 조성물.The cosmetic composition according to claim 1, which contains 0.0001-10.0% by weight of a carcass, a paw, and a raal extract in dry weight. 제 1항에 있어서, 시체, 마발, 랄료를 물이나 탄소수 1-4의 저급알코올, 에틸아세테이트 또는 아세톤으로 1회 이상 추출하고, 추출액을 감압증류한 후 동결건조하거나 분사건조하여 얻은 것임을 함유하는 추출물임을 특징으로 하는 화장료 조성물.The extract according to claim 1, which is obtained by extracting the carcass, the bristles and the rallies with water or a lower alcohol having 1 to 4 carbon atoms, ethyl acetate or acetone at least once, and distilling the extract under reduced pressure followed by freeze drying or spray drying. Cosmetic composition characterized in that.
KR1019990032359A 1999-08-06 1999-08-06 Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper KR100585468B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990032359A KR100585468B1 (en) 1999-08-06 1999-08-06 Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990032359A KR100585468B1 (en) 1999-08-06 1999-08-06 Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper

Publications (2)

Publication Number Publication Date
KR20010017053A true KR20010017053A (en) 2001-03-05
KR100585468B1 KR100585468B1 (en) 2007-04-12

Family

ID=19606437

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990032359A KR100585468B1 (en) 1999-08-06 1999-08-06 Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper

Country Status (1)

Country Link
KR (1) KR100585468B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020080656A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for antioxidation
KR20020080655A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for skin whitening
KR20210066030A (en) * 2009-08-26 2021-06-04 마리 케이 인코포레이티드 Topical skin care formulations comprising plant extracts

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104027287A (en) * 2014-07-08 2014-09-10 广州千百度化妆品有限公司 Free radical scavenging cosmetic composition and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020080656A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for antioxidation
KR20020080655A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for skin whitening
KR20210066030A (en) * 2009-08-26 2021-06-04 마리 케이 인코포레이티드 Topical skin care formulations comprising plant extracts
US11419810B2 (en) 2009-08-26 2022-08-23 Mary Kay Inc. Topical skin care formulations comprising plant extracts

Also Published As

Publication number Publication date
KR100585468B1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
KR20060121496A (en) Whitening composition comprising an extract of broussonetia kazinoki var. humilis
KR20150143375A (en) Anti-wrinkle cosmetic composition comprising essentially Polygonum multiflorum adventitious extract
KR100544024B1 (en) Skin whitening compound
KR20010027448A (en) Cosmetic compositions
KR102255580B1 (en) Cosmetic composition comprising Ilex paraguayensis extract and Tranexamic acid
JP3648730B2 (en) Skin cosmetics
KR100441596B1 (en) cosmetic composition containing plant extract complex
KR100797367B1 (en) Cosmetic composition containing Veratrum nigrum L. extracts
KR100585468B1 (en) Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper
KR100789632B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR100546735B1 (en) Skin Whitening Composition
KR100466379B1 (en) Composition for skin whitening
KR100564227B1 (en) Cosmetic material composition for skin whitening
KR101214347B1 (en) Method for Extracting Herbal Ingredient
KR100463081B1 (en) Cosmetic compositions containing Phaseolus aureus extracts for skin whitening
US5866133A (en) Tanning cosmetics containing Caesapinia sappan L. extract
KR100789634B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20020029181A (en) Cosmetic composition containing Liquidambar taiwaniana Hance extracts and Cynanchum atratum Bunge extracts
KR100562369B1 (en) Cosmetic composition containing extracts of Cortex Hibisci, Resina Liquidambaris or Hypericum chinese L.
KR19990085941A (en) Whitening cosmetic composition containing grape extract
KR100789635B1 (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100789631B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR102435602B1 (en) Cosmetic composition for skin improvement containing aloe vera adventitious root extract
KR0147412B1 (en) Whitening cosmetics containing purified morus marus cortex, fructus extract and kojic acid
KR20050092314A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee